These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13224731)

  • 1. Potentiating effect of iproniazid on action of some sympathicomimetic amines.
    REBHUN J; FEINBERG SM; ZELLER EA
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):218-20. PubMed ID: 13224731
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiating effect of iproniazid on the pharmacological action of sympathomimetic amines.
    GRIESEMER EC; BARSKY J; DRAGSTEDT CA; WELLS JA; ZELLER EA
    Proc Soc Exp Biol Med; 1953 Dec; 84(3):699-701. PubMed ID: 13134261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modifications in the effects of various sympathomimetic amines on the nictating membrane of cat induced by an aminoxydase inhibitor, iproniazid].
    GONNARD P; SCHMITT H
    Arch Int Pharmacodyn Ther; 1956 Oct; 108(1):74-83. PubMed ID: 13382382
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral synaptic inhibition by serotonin and iproniazid.
    GLUCKMAN MI; HART ER; MARRAZZI AS
    Science; 1957 Sep; 126(3271):448-9. PubMed ID: 13467225
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of the effects of sympathomimetic amines and of adrenergic nerve stimulation by 1-isonicotinyl-2-isopyropylhydrazine (IIH) and isonicotinic acid hydrazide (INH).
    KAMIJO K; KOELLE GB; WAGNER HH
    J Pharmacol Exp Ther; 1956 Jun; 117(2):213-27. PubMed ID: 13332565
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of reserpine and iproniazid (marsilid) on space localization.
    KRUS DM; WAPNER S; FREEMAN H
    AMA Arch Neurol Psychiatry; 1958 Dec; 80(6):768-70. PubMed ID: 13593921
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic characterization of reserpine responses in rats pretreated with iproniazid.
    FRANCO-BROWDER S; MASSON GM; CORCORAN AC
    Proc Soc Exp Biol Med; 1958 Apr; 97(4):778-80. PubMed ID: 13554480
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of isoniazid and iproniazid on the central nervous system of the dog.
    SCHALLEK W; WALZ D
    Am Rev Tuberc; 1954 Feb; 69(2):261-6. PubMed ID: 13114643
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of monoamine oxidase inhibitory effects of iproniazid and its phenyl congener.
    HORITA A; PARKER RG
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):617-9. PubMed ID: 13614441
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of the irreversible inhibition of rat-liver monoamine oxidase by iproniazid (marsilid).
    DAVISON AN
    Biochem J; 1957 Oct; 67(2):316-22. PubMed ID: 13471553
    [No Abstract]   [Full Text] [Related]  

  • 11. Iproniazid treatment and metabolism of labeled epinephrine in schizophrenics.
    RESNICK O; WOLFE JM; FREEMAN H; ELMADJIAN F
    Science; 1958 May; 127(3306):1116-7. PubMed ID: 13555854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histochemical findings on the effect of iproniazid on reserpineinduced depletion of epinephrine & arterenol from the adrenal medulla].
    ZBINDEN G; STUDER A
    Experientia; 1958 Jun; 14(6):201-3. PubMed ID: 13562053
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental tuberculous meningitis in guinea pigs: results of treatment with isoniazid, iproniazid, streptomycin, and isoniazid-streptomycin.
    WOLINSKY E; PRATT P; STEENKEN W
    Am Rev Tuberc; 1954 Oct; 70(4):714-27. PubMed ID: 13197747
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of iproniasid on response of nictitating membrane of cat to sympathomimetics].
    SCHMITT H; GONNARD P
    C R Hebd Seances Acad Sci; 1955 Jun; 240(26):2573-5. PubMed ID: 13240889
    [No Abstract]   [Full Text] [Related]  

  • 15. TOXICITY of iproniazid.
    J Am Med Assoc; 1958 Sep; 168(1):50. PubMed ID: 13575123
    [No Abstract]   [Full Text] [Related]  

  • 16. Some pharmacological observations on isoniazid and iproniazid.
    ALLMARK MG; LU FC; CARMICHAEL E; LAVALLEE A
    Am Rev Tuberc; 1953 Aug; 68(2):199-206. PubMed ID: 13065685
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of iproniazid in depressive syndromes.
    WEST ED; DALLY PJ
    Br Med J; 1959 Jun; 1(5136):1491-4. PubMed ID: 13651775
    [No Abstract]   [Full Text] [Related]  

  • 18. Side effects accompanying use of iproniazid.
    O'CONNOR JB; HOWLETT KS; WAGNER RR
    Am Rev Tuberc; 1953 Aug; 68(2):270-2. PubMed ID: 13065695
    [No Abstract]   [Full Text] [Related]  

  • 19. Iproniazid therapy of psoriasis.
    WITTEN VH; SULZBERGER MB; MARCH C; DVORINE W
    J Am Med Assoc; 1959 Feb; 169(6):591-3. PubMed ID: 13620511
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathological findings in jaundice associated with iproniazid therapy.
    POPPER H
    J Am Med Assoc; 1958 Dec; 168(17):2235-42. PubMed ID: 13610612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.